Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs
Crossref DOI link: https://doi.org/10.1186/s12879-015-1115-5
Published Online: 2015-09-17
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Duintjer Tebbens, Radboud J.
Pallansch, Mark A.
Thompson, Kimberly M.
License valid from 2015-09-17